Picture of Alteration Earth logo

ALTE Alteration Earth News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

REG - Alteration Earth PLC - Half-year Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240502:nRSB0485Na&default-theme=true

RNS Number : 0485N  Alteration Earth PLC  02 May 2024

 

2 May 2024

 

Alteration Earth PLC

 

Interim Condensed Financial Statements

Half Year to 31 March 2024

 

Alteration Earth PLC (the "Company") announces its unaudited interim results
for the half year ended 31 March 2024.

 

Copies of this interim report will be made available on the Company's website
www.altearthplc.com (http://www.altearthplc.com)

 

Enquiries

For further information, please visit www.altearthplc.com
(http://www.altearthplc.com) or contact:

 

Alteration Earth PLC

Matthew Beardmore

Director

T: +44 (0)20 4501 8549

Email: info@altearthplc.com (mailto:info@altearthplc.com)

 

 

 

 

Interim Management Report

The Company was formed to undertake an acquisition of a target company or
business or asset(s) in the clean technology and/or clean, green and renewable
energy sector. The Company's shares began trading on the standard list segment
of the London Stock Exchange's ("LSE") main market for listed securities on 1
July 2022. We continue to progress the Company's objectives as outlined in the
prospectus dated 17 June 2022.

The Company announced on 1 August 2023 that it has entered non-binding heads
of terms for a proposed acquisition which remains subject to legal and
financial due diligence and entry into a legally binding agreement before the
proposed acquisition may proceed to completion. Whilst discussions and the due
diligence exercise continues to be progressed, the parties have not yet
progressed to a binding agreement. As reported by the Company on 12 December
2023, progress has been slower than originally anticipated while the parties
seek feedback from prospective financial partners.

Whilst the effects of macroeconomic and geopolitical uncertainty throughout
2023 have continued into 2024, having a significant impact on equity capital
markets in the United Kingdom, it is hoped that markets will improve during
this year. Given the significant levels of public M&A activity which
occurred in Q1 2024 in the United Kingdom, which has continued into Q2, it is
hoped that this will act as a positive driver for increased equity capital
activity which will assist the Company and its partners in progressing
fundraising discussions concurrent with the proposed completion of its
acquisition.

Principal risks and uncertainties

The principal risks and uncertainties facing our business are monitored on an
ongoing basis. The directors have reviewed the principal risks and
uncertainties disclosed in the 2023 Annual Report and concluded that they
remain applicable for the first half of the current financial year. A detailed
description of these risks and uncertainties is set out on pages 3 to 4 of the
2023 annual report.

 

Martin Samworth, Director

2 May 2024

 

 

Statement of Directors' Responsibilities

The directors are responsible for preparing the interim management report in
accordance with applicable law and regulations. The directors confirm that the
interim condensed financial information has been prepared in accordance with
International Accounting Standard 34 (Interim Financial Reporting) as endorsed
for use in the United Kingdom.

The interim management report includes a fair review of the information
required by the Disclosure Guidance and Transparency Rules paragraphs 4.2.7 R
and 4.2.8 R, namely:

•     the interim condensed financial statements, which have been
prepared in accordance with applicable accounting standards, give a true and
fair view of the assets, liabilities, financial position, and profit or loss
of the issuer as required by DTR 4.2.4 R;

•     an indication of important events that have occurred during the
six months ended 31 March 2024 and their impact on the condensed set of
financial information; and

•     material related-party transactions during the six months ended 31
March 2024 and any material changes in the related-party transactions
described in the 2023 Annual Report.

The interim management report was approved by the Board of Directors and the
above responsibility statement was signed on its behalf by:

 

Matthew Beardmore, Director

2 May 2024

 

 

Condensed Income Statement and Statement of Other Comprehensive Income

for the Period 1 October 2023 to 31 March 2024

 

                                                      1 October 2023      1 October 2022

                                                      to                  to

                                                      31 March 2024       31 March 2023
                                               Notes  £                   £
 Revenue                                              -                   -
 Administration expenses                              (151,301)           (129,646)

 OPERATING LOSS                                       (151,301)           (129,646)

 LOSS BEFORE INCOME TAX                               (151,301)           (129,646)
 Income tax                                    5               -                   -
 LOSS AFTER INCOME TAX                                (151,301)           (129,646)
 OTHER COMPREHENSIVE INCOME

                                                      -                   -
 TOTAL COMPREHENSIVE LOSS FOR THE PERIOD              ________            ________

                                                      (151,301)           (129,646)

 Loss per share expressed in pence per share:

                                               6
 Basic                                                (0.84)              (0.72)
 Diluted                                              (0.84)              (0.72)

 

 

Notes:

(i)   The Income Statement has been prepared on the basis that all
operations are continuing operations.

(i)   The accounting policies and notes form an integral part of these
condensed financial statements.

 

 

Condensed Statement of Financial Position at 31 March 2024

(Unaudited)

 

                                          As at      As at

                                          31 March   30 September

                                          2024       2023
                                   Notes  £          £
 ASSETS
 CURRENT ASSETS
 Other receivables                 7      13,975     25,800
 Cash and cash equivalents         8      716,849    828,215
 TOTAL CURRENT ASSETS                     730,824    854,015
 TOTAL ASSETS                             730,824    854,015

 EQUITY AND LIABILITIES
 EQUITY ATTRIBUTABLE TO OWNERS
 Share capital                     9      54,000     54,000
 Share premium                     10     941,522    941,522
 Other reserves                    10     232,500    217,500
 Accumulates losses                10     (567,844)  (416,543)
 TOTAL EQUITY                              660,178    796,479

 LIABILITIES
 CURRENT LIABILITIES
 Trade and other payables          11      70,646     57,536
 TOTAL LIABILITIES                         70,646     57,536

 TOTAL EQUITY AND LIABILITIES             730,824    854,015

 

 

 

 

The condensed financial statements were approved by the Board of Directors and
authorised for issue on 2 May 2024 and were signed on its behalf by:

 

 

Matthew Beardmore, Director

2 May 2024

 

Statement of Changes in Equity

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

 
Called up

 
share          Retained
Share             Other             Total

 
capital          earnings        premium
reserves          equity

 
£
£
£
£                    £

 

Period 1 October 2023 to 31 March 2024

 

Balance at 1 October 2023              54,000
(416,543)        941,522         217,500
796,479

Deficit for the
period
-        (151,301)
-                     -        (151,301)

Share based payment reserve
-
-                     -
15,000           15,000

 

Balance at 31 March 2024                 54,000      (567,844)
     941,522          232,500          660,178

 

Period 1 October 2022 to 31 March 2023

 

Balance at 1 October 2022              54,000
(143,128)        941,522         187,500      1,039,894

Deficit for the
period
-        (129,646)
-                     -        (129,646)

Share based payment reserve
-
-                     -
15,000           15,000

 

Balance at 31 March 2023              54,000
(272,774)        941,522          202,500          925,248

Consolidated Statement of Cash Flows

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

                                                          1 October 2023  1 October 2022  18 August 2021

                                                          to              to               to

                                                          31 March 2024   31 March 2023   31 March 2022
                                                   Notes  £               £               £
 Change in working capital                         1      (111,366)       (136,999)                -

 Increase/(decrease) in cash and cash equivalents

                                                          (111,366)       (136,999)       1,148,522
 Cash and cash equivalents at beginning of period  2

                                                          828,215         1,069,939       -

                                                          ________        ________        ________
 Cash and cash equivalents at end of period

                                                            716,849         932,940       1,148,522

 

 

 

 

 

 

Notes to the Statement of Cash Flows

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

 1.  RECONCILIATION OF LOSS BEFORE INCOME TAX TO CHANGES IN WORKING CAPITAL

                                         1 October 2023  1 October 2022  18 August 2021

                           to              to              to

                          31 March 2024   31 March 2023   31 March 2022
                          £               £               £
     Loss before income tax                   (151,301)       (129,646)       (21,553)
     Decrease in trade and other receivables  11,825          2,286           -
     Decrease in trade and other payables     13,110          (24,639)        21,553
     Non-cash costs share based payments         15,000          15,000                -

     Working capital movement                 (111,366)       (136,999)                -

 

 

2.       CASH AND CASH EQUIVALENTS

 

The amounts disclosed on the Statement of Cash Flows in respect of cash and
cash equivalents are in respect of these Statement of Financial Position
amounts:

 

          Period ended 31 March 2024

 
31 March  31 March

 
2024              2023

 
£                    £

          Cash and cash
equivalents
716,849         932,940

Notes to the Condensed Financial Statements

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

1.       STATUTORY INFORMATION

 

Alteration Earth Plc (the 'Company') was incorporated on 18 August 2021 in
England and Wales, with registered number 13571750 under Companies Act 2006.
The registered office of the company is c/o Keystone Law, 48 Chancery Lane,
London, WC2A 1JF. The Company is a public limited company and was admitted to
the Standard Listing Segment of the London Stock Exchange on 1 July 2022. The
principal activity of the Company is to undertake an acquisition of a
controlling interest in a company or business in the Clean, Green, Renewable
Energy (CGRE) sector.

 

2.       ACCOUNTING POLICIES

 

          Basis of preparation

 

These financial statements have been prepared in accordance with UK-adopted
international accounting standards and with those parts of the Companies Act
2006 applicable to companies reporting under IFRS. The financial statements
have been prepared under the historical cost convention.

 

The principal accounting policies are set out below and have, unless otherwise
stated, been applied consistently for all periods presented in these Financial
Statements. The Financial Statements are prepared in pounds Sterling and
presented to the nearest pound.

 

Going concern

 

The financial statements have been prepared on a going concern basis, which
assumes that the Company will continue in operational existence for the
foreseeable future.

 

The Company has no revenue but has cash resources to finance activities whilst
it identifies and completes suitable transaction opportunities. When a
suitable transaction is identified, the Directors will consider the need for
further funding to complete the transaction.

 

Having considered forecasts, the Directors consider that the Company has
sufficient funds available to continue in operational existence for at least
12 months from the date of approval of these accounts. Accordingly, the Board
believes it appropriate to adopt the going concern basis in the approval of
the financial statements.

 

Accounting standards

 

There are no new standards, amendments and interpretations adopted by the
Company.

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

New standards and interpretations not yet adopted

 

A number of new standards and amendments to standards and interpretations are
effective for annual periods beginning after 1 October 2022 and have not been
applied in preparing these financial statements. None of these are expected to
have a significant effect on the financial statements of the Company.

 

 

There are no other IFRSs or IFRIC interpretations that are not yet effective
that would be expected to have a material impact on the Company.

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

Critical accounting judgements and key sources of estimation uncertainty

 

In the process of applying the entity's accounting policies, management makes
estimates and assumptions that have an effect on the amounts recognised in the
financial information. Although these estimates are based on management's best
knowledge of current events and actions, actual results may ultimately differ
from those estimates. Apart from share based payments and share issue costs
discussed below the Directors consider that there are no other critical
accounting judgements or key sources of estimation uncertainly relating to the
financial information of the Company.

 

Cash and cash equivalents

 

Cash represents cash in hand and deposits held on demand with financial
institutions. Cash equivalents are short-term, highly-liquid investments with
original maturities of three months or less (as at their date of acquisition).
Cash equivalents are readily convertible to known amounts of cash and subject
to an insignificant risk of change in that cash value.

 

In the presentation of the Statement of Cash Flows, cash and cash equivalents
also include bank overdrafts. Any such overdrafts are shown within borrowings
under 'current liabilities' on the Statement of Financial Position.

 

Financial instruments recognition

 

A financial asset or financial liability is recognised in the statement of
financial position of the Company when it arises or when the Company becomes
part of the contractual terms of the financial instrument.

 

Classification

 

Financial assets at amortised cost

 

The Company measures financial assets at amortised cost if both of the
following conditions are met:

 

(1) the asset is held within a business model whose objective is to collect
contractual cashflows; and

 

(2) the contractual terms of the financial asset generating cash flows at
specified dates only pertain to capital and interest payments on the balance
of the initial capital.

 

Financial assets which are measured at amortised cost, are measured using the
Effective Interest Rate Method (EIR) and are subject to impairment. Gains and
losses are recognised in profit or loss when the asset is derecognised,
modified or impaired.

 

Financial liabilities at amortised cost

 

Financial liabilities measured at amortised cost using the effective interest
rate method include current borrowings and trade and other payables that are
short term in nature. Financial liabilities are derecognised if the Company's
obligations specified in the contract expire or are discharged or cancelled.

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

Financial liabilities at amortised cost - continued

 

Amortised cost is calculated by taking into account any discount or premium on
acquisition and fees or costs that are an integral part of the effective
interest rate ("EIR"). The EIR amortisation is included as finance costs in
profit or loss. Trade payables other payables are non-interest bearing and are
stated at amortised cost using the effective interest method.

 

Derecognition

 

A financial asset is derecognised when:

 

(1) the rights to receive cash flows from the asset have expired, or

 

(2) The Company has transferred its rights to receive cash flows from the
asset or has assumed an obligation to pay the received cash flows in full
without material delay to a third party under a 'pass-through' arrangement;
and either (a) the Company has transferred substantially all the risks and
rewards of the asset, or (b) the Company has neither transferred nor retained
substantially all the risks and rewards of the asset but has transferred
control of the asset.

 

Impairment

 

The Company recognises a provision for impairment for expected credit losses
regarding all financial assets. Expected credit losses are based on the
balance between all the payable contractual cash flows and all discounted cash
flows that the Company expects to receive. Regarding trade receivables, the
Company applies the IFRS 9 simplified approach in order to calculate expected
credit losses. Therefore, at every reporting date, provision for losses
regarding a financial instrument is measured at an amount equal to the
expected credit losses over its lifetime without monitoring changes in credit
risk. To measure expected credit losses, trade receivables and contract assets
have been grouped based on shared risk characteristics.

 

Taxation

 

Tax currently payable is based on taxable profit for the period. Taxable
profit differs from profit as reported in the income statement because it
excludes items of income and expense that are taxable or deductible in other
years and it further excludes items that are never taxable or deductible. The
Company's liability for current tax is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.

 

Deferred tax is recognised on differences between the carrying amounts of
assets and liabilities in the financial statements and the corresponding tax
bases used in the computation of taxable profit and is accounted for using the
balance sheet liability method. Deferred tax liabilities are generally
recognised for all taxable temporary differences and deferred tax assets are
recognised to the extent that it is probable that taxable profits will be
available against which deductible temporary differences can be utilised. Such
assets and liabilities are not recognised if the temporary difference arises
from initial recognition of goodwill or from the initial recognition (other
than in a business combination) of other assets and liabilities in a
transaction that affects neither the taxable profit nor the accounting profit.

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

Taxation - continued

 

The carrying amount of deferred tax assets is reviewed at each balance sheet
date and reduced to the extent that it is no longer probable that sufficient
taxable profits will be available to allow all or part of the asset to be
recovered.

 

Deferred tax is calculated at the tax rates that are expected to apply in the
period when the liability is settled, or the asset realised. Deferred tax is
charged or credited to profit or loss, except when it relates to items charged
or credited directly to equity, in which case the deferred tax is also dealt
with in equity.

Deferred tax assets and liabilities are offset when there is a legally
enforceable right to set off current tax assets against current tax
liabilities and when they relate to income taxes levied by the same taxation
authority and the Company intends to settle its current tax assets and
liabilities on a net basis.

 

 Foreign currency translation

 

The financial information is presented in Sterling which is the Company's
functional and presentational currency.

 

Transactions in currencies other than the functional currency are recognised
at the rates of exchange on the dates of the transactions. At each balance
sheet date, monetary assets and liabilities are retranslated at the rates
prevailing at the balance sheet date with differences recognised in the
Statement of comprehensive income in the period in which they arise.

 

 Equity

 

Share capital is determined using the nominal value of shares that have been
issued.

 

The Share premium account includes any premiums received on the initial
issuing of the share capital. Any transaction costs associated with the
issuing of shares are deducted from the Share premium account, net of any
related income tax benefits.

 

Equity-settled share-based payments are credited to a share-based payment
reserve as a component of equity until related options or warrants are
exercised or lapse.

 

Accumulated losses include all current and prior period results as disclosed
in the income statement.

 

Share Based Payments

 

Equity-settled share-based payments are measured at fair value (excluding the
effect of non-market based vesting conditions) at date of grant. The fair
value so determined is expensed on a straight-line basis over the vesting
period, based on the Company's estimate of the number of shares that will
eventually vest and adjusted for the effect of non-market based vesting
conditions. Fair value is measured using the Black Scholes pricing model. The
key assumption used in the model have been adjusted, based on management's
best estimate, for the effects of non-transferability, exercise restrictions
and behavioural considerations.

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

Share based payments: share warrants

The Company issued warrants to the lead investor and two directors on 1 July
2022. Equity-settled share-based payments are measured at fair value
(excluding the effect of non-market based vesting conditions) at date of
grant. The fair value so determined is expensed on a straight-line basis over
the vesting period, based on the Company's estimate of the number of shares
that will eventually vest and adjusted for the effect of non-market based
vesting conditions. Fair value is measured using the Black Scholes pricing
model. The key assumption used in the model have been adjusted, based on
management's best estimate of the vesting period and volatility.

Share Issue costs

The costs of share issues are charged against the share premium account. Where
the share issue costs are incurred concurrently with another activity such as
a stock market admission and/or an issue of a prospectus or admission document
then the costs of these activities can be difficult to quantify separately and
therefore reliance is placed on management's best estimate of the split of the
costs.

 

Loss per share

 

Basic loss per share is calculated as the profit or loss attributable to
equity holders of the Company for the period, adjusted to exclude any costs of
servicing equity (other than dividends), divided by the weighted average
number of ordinary shares.

 

Diluted EPS is calculated by dividing the profit attributable to ordinary
equity holders of the Company by the weighted average number of ordinary
shares outstanding during the period plus the weighted average number of
ordinary shares that would be issued on conversion of all the dilutive
potential ordinary shares into ordinary shares.

 

Segmental reporting

 

Operating segments are reported in a manner consistent with the internal
reporting provided to the chief operating decision-maker.

 

The chief operating decision-maker, who is responsible for allocating
resources and assessing performance of the operating segments, has been
identified as the Board as a whole.

 

Identifying and assessing investment projects is the only activity the Company
is involved in and is therefore considered as the only operating/reporting
segment. Therefore, the financial information of the single segment is the
same a set out in the statement of comprehensive income and statement of
financial position.

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

2.       ACCOUNTING POLICIES - continued

 

Cash and cash equivalents

Cash represents cash in hand and deposits held on demand with financial
institutions. Cash equivalents are short-term, highly-liquid investments with
original maturities of three months or less (as at their date of
acquisition).  Cash equivalents are readily convertible to known amounts of
cash and subject to an insignificant risk of change in that cash value.

 

In the presentation of the Statement of Cash Flows, cash and cash equivalents
also include bank overdrafts. Any such overdrafts are shown within borrowings
under 'current liabilities' on the Statement of Financial Position.

 

          Taxation

Tax currently payable is based on taxable profit for the period. Taxable
profit differs from profit as reported in the income statement because it
excludes items of income and expense that are taxable or deductible in other
years and it further excludes items that are never taxable or deductible. The
Company's liability for current tax is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.

 

Deferred tax is recognised on differences between the carrying amounts of
assets and liabilities in the financial statements and the corresponding tax
bases used in the computation of taxable profit and is accounted for using the
balance sheet liability method. Deferred tax liabilities are generally
recognised for all taxable temporary differences and deferred tax assets are
recognised to the extent that it is probable that taxable profits will be
available against which deductible temporary differences can be utilised. Such
assets and liabilities are not recognised if the temporary difference arises
from initial recognition of goodwill or from the initial recognition (other
than in a business combination) of other assets and liabilities in a
transaction that affects neither the taxable profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each balance sheet
date and reduced to the extent that it is no longer probable that sufficient
taxable profits will be available to allow all or part of the asset to be
recovered.

 

Deferred tax is calculated at the tax rates that are expected to apply in the
period when the liability is settled, or the asset realised. Deferred tax is
charged or credited to profit or loss, except when it relates to items charged
or credited directly to equity, in which case the deferred tax is also dealt
with in equity.

Deferred tax assets and liabilities are offset when there is a legally
enforceable right to set off current tax assets against current tax
liabilities and when they relate to income taxes levied by the same taxation
authority and the Company intends to settle its current tax assets and
liabilities on a net basis.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

 

3.       EMPLOYEES AND DIRECTORS

 

The average number of employees during the period was NIL.

 

                                                          1 October 2023 to 31 March 2024  1 October 2022 to 31 March 2023
                                                          £                                £
 Directors' remuneration: fair value of warrants granted

                                                          15,000                           15,000

 

 

4.       LOSS BEFORE INCOME TAX

 

The loss before income tax is stated after charging:

 

                          1 October 2023 to 31 March 2024  1 October 2022 to 31 March 2023
                          £                                £
 Auditors' remuneration:

                          18,000                           17,000

5.        INCOME TAX

Analysis of tax expense

No liability to UK corporation tax arose for the period 1 October 2023 to 31
March 2024 nor for the period 1 October 2022 to 31 March 2023.

 

A reconciliation of the tax charge / credit appearing in the income statement
to the tax that would result from applying the standard rate of tax to the
results for the period is:

 

                                                                              1 October 2023  1 October 2022

                                                                              to              to

                                                                              31 March 2024   31 March 2023
     £                                                                        £

     Loss for the period                                                      (151,301)       (129,646)
     Tax credit at the Company's effective rate of corporation tax            (37,825)        (24,633)
     Impact of losses disallowed for tax purposes                             3,750           2,850
     Effect of tax losses available for carry forward against future profits  34,075          21,783

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

5.        INCOME TAX - CONTINUED

Analysis of tax expense - continued

The Company's unutilised tax losses carried forward at 31 March 2024 amounted
to £452,826 (at 31 March 2023: £187,456). A deferred tax asset has not been
recognised due to uncertainty over the timing of the utilisation of the
losses.

Effective corporate tax rate

The standard rate of corporation tax in the UK from 1 April 2023 is 25%, prior
to which the rate was 19%. Accordingly, the Company's effective rate of
corporation tax for the period 1 October 2023 to 31 March 2024 was 25% (1
October 2022 to March 2023: 19%).

 

6.    EARNINGS PER SHARE

 

Basic EPS is calculated by dividing the earnings attributable to ordinary
shareholders by the weighted average number of ordinary shares outstanding
during the period.

 

Diluted EPS is calculated by dividing the profit attributable to ordinary
equity holders of the Company by the weighted average number of ordinary
shares outstanding during the period plus the weighted average number of
ordinary shares that would be issued on conversion of all the dilutive
potential ordinary shares into ordinary shares.

 

Reconciliations are set out below.

 
Weighted

 
average

 
number       Per-share

 
Earnings             of               amount

 
£                shares             pence

          Basic and Diluted EPS

   Earnings attributable to ordinary shareholders:

   1 October 2023 to 31 March 2024                  (151,301)   18,000,000   (0.84)

   1 October 2022 to 31 March 2023                  (129,646)   18,000,000   (0.72)

 

Diluted EPS are not separately calculated as the warrants would be
anti-dilutive due to the loss, the weighted average number of shares including
the dilution shares is 20,700,000.

 

7.       TRADE AND OTHER RECEIVABLES

 

              31 March 2024  30 September 2023
              £              £
 Current:
 Prepayments  13,975         25,800

              13,975         25,800

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

8.       CASH AND CASH EQUIVALENTS

 

               31 March 2024  30 September 2023
               £              £

 Bank account  716,849        828,215

               716,849        828,215

 

 

9.       SHARE CAPITAL AND SHARE PREMIUM

 

                                                                      No. of       Share Capital  Share

                                                                      Shares                      Premium     Total
                                                                                   £              £           £

   Issued on Incorporation
   Ordinary shares of £0.001 each                                     2            0.002          -           0.002
   Issued on 23 November 2021 Consolidation of shares on 29 November  4            0.004          -           0.004
   2021 to £0.003 each                                                2            0.006          -           0.006
   Issued on 1 July 2022 at £0.04 each seed
   price                                                              8,999,998    27,000         333,000     360,000
   Issued on 1 July 2022 at £0.10 each
   subscription price                                                 9,000,000    27,000         873,000     900,000

   As at 31 March 2024                                                18,000,000   54,000         1,206,000   1,260,000

   As at 30 September 2023                                            18,000,000   54,000         1,206,000   1,260,000

 

The Company has only one class of share. All ordinary shares have equal voting
rights and rank pari passu for the distribution of dividends and repayment of
capital.

 

10.     RESERVES

 

                               Retained Earnings      Share Premium      Other Reserves      Totals

                               £                      £                  £                   £

 At 1 October 2023             (416,543)              941,522            217,500             742,479
 Loss for the period           (151,301)              -                  -                   (151,301)
 Share based payments charges  -                      -                  15,000              15,000

 At 31 March 2024              (567,844)              941,522            232,500             660,178

 

 

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

 

11.     TRADE AND OTHER PAYABLES

 

                 31 March 2024  30 September 2023
                 £              £
 Current:
 Trade payables  6,964          -
 Accruals        63,682         57,536

                 70,646         57,536

 

 

12.     FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Company's financial instruments comprise primarily of bank balances. The
main purpose of these financial instruments is to provide working capital for
the Company's operations. The Company does not utilise complex financial
instruments or hedging mechanisms. The company is not trading nor carrying out
any business activities and therefore has not disclosed in this note below all
of the disclosure items set out in IFRS7 as they are not considered material
and relevant to its current status.

 

Financial assets by category

                                                             31 March 2024  30 September 2023
                                                             £              £
 Current assets
 Cash and cash equivalents                                   716,849        828,215
 Categorised as financial assets measured at amortised cost

                                                             716,849        828,215

 

                         Financial liabilities by
category

 

                                                             31 March 2024  30 September 2023
                                                             £              £
 Current liabilities
 Trade payables                                              6,964          -
 Accruals                                                    63,682         57,536
 Categorised as financial assets measured at amortised cost

                                                             70,646         57,536

 

Credit risk

 

Credit risk is the risk that a counterparty will not meet its obligations
under a financial instrument or customer contract, leading to a financial
loss. The Company does not have trading activities during the current period
and is not exposed to a risk from counterparties not meeting their
obligations.

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

12.     FINANCIAL INSTRUMENTS AND RISK MANAGEMENT - CONTINUED

 

Capital management

 

The Company considers its capital to be equal to the sum of its total equity.
The Company monitors its capital using a number of key performance indicators
including cash flow projections, working capital ratios, the cost to achieve
development milestones and potential revenue from partnerships and ongoing
licensing activities.

 

The Company's objective when managing its capital is to ensure it obtains
sufficient funding for continuing as a going concern. The Company funds its
capital requirements through the issue of new shares to investors.

 

Interest rate risk

 

The nature of the Company's activities and the basis of funding are such that
the Company will have significant liquid resources. The Company will use these
resources to meet the cost of operations.

 

The Company is not financially dependent on the income earned on these
resources and therefore the risk of interest rate fluctuations is not
significant to the business and the Directors have not performed a detailed
sensitivity analysis.

 

Liquidity risk

 

The Company's liquid resources are invested having regard to the timing of
payment to be made in the ordinary course of the Company's activities. All
financial liabilities are payable in the short term (between 0 to 3 months)
and the Company maintains adequate bank balances to meet those liabilities.
The directors have considered the Company's cash flows for a period of 12
months from the date of approval of these financial statements and do not
consider that the Company is subject to any significant liquidity risk.

 

Currency risk

 

The Company operates in a global market with income and costs possibly arising
in a number of currencies. The majority of the operating costs are incurred in
GBP (£). The Company does not hedge potential future income or costs, since
the existence, quantum and timing of such transactions cannot be accurately
predicted. The Company did not have foreign currency exposure at period end.

 

 

13.     CONTINGENT LIABILITIES

 

There were no contingent liabilities at either 31 March 2024 or 30 September
2023.

 

14.     CAPITAL COMMITMENTS

 

There were no capital commitments at either 31 March 2024 or 30 September
2023.

 

 

Notes to the Condensed Financial Statements - continued

for the Period 1 October 2023 to 31 March 2024

(Unaudited)

 

 

15.     RELATED PARTY DISCLOSURES

 

a) Key managerial personnel

 

M Beardmore is a director of the Company and in a previous financial period
subscribed £28,000 for shares in the Company, he was also granted 450,000
warrants on 1 July 2022 which have been fair valued at £45,000 and the charge
for these in the period 1 October 2023 to 31 March 2024 was £7,500 (1 October
2022 to 31 March 2023: £7,500). There are no amounts outstanding between M
Beardmore and the Company at 31 March 2024 and at 30 September 2023.

 

b) Other related parties

 

S Holden has been the Company Secretary from incorporation to the date of
approval of these financial statements. He subscribed £28,000 for shares in
the Company after ceasing to hold office as a director through his wholly
owned company Golden Sky Advisory Limited (GSAL). GSAL provides the services
of S Holden as Company Secretary to the Company and those totalled £18,000
inclusive of VAT during the period 1 October 2023 to 31 March 2024 (1 October
2022 to 31 March 2023: £18,000). An amount of £6,000 was outstanding between
GSAL and the Company at 31 March 2024 (30 September 2023: £ nil).

 

 

Primorus Investments PLC (Prim) had a 27.78% stake in the Company on its
Admission to the LSE standard Listing segment and it underwrote the costs of
the Admission. Prim subscribed £350,000 for shares in the Company. It also
advanced £21,552 to the Company to re-imburse certain of the Company's
Admission costs and this sum was repaid to Prim post Admission. Prim was
granted 1,800,000 warrants on 1 July 2022 which have been fair valued at
£180,000 and fully charged in the period. There were no transactions with
Prim during the period and no amounts outstanding between Prim and the Company
at 31 March 2024 and at 30 September 2023.

 

Gneiss Energy Limited (GEL) has acted as a corporate finance consultant to the
Company with effect from 1 July 2022. GEL invoiced a total of £27,000
inclusive of VAT during the period 1 October 2023 to 31 December 2023 and the
Company has accrued £36,000 inclusive of VAT for the period 1 January to 31
March 2024 (1 October 2022 to 31 March 2023: £36,000). The charge is for
corporate finance advice by GEL and not for director services. A Coull is an
employee of GEL and a director of the Company as stipulated in the engagement
terms of GEL. There were no other amounts outstanding between GEL and the
Company at 31 March 2024 and at 30 September 2023.

 

16.     EVENTS AFTER THE REPORTING PERIOD

 

There were no significant events of the Company subsequent to the period end.

 

17.     ULTIMATE CONTROLLING PARTY

 

In the opinion of the directors there is no single ultimate controlling party
at 31 March 2024 and at 30 September 2023.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IR BDGDULDGDGSD

Recent news on Alteration Earth

See all news